The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha
- PMID: 2647849
The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha
Abstract
We have previously demonstrated that incubation with IL-2 can induce ADCC activity in murine cells and that this activity was mediated by asialo GM1+, FcR+ cells. In the present study we show that the cytokines IFN-alpha and IFN-gamma, TNF-alpha, and IL-1 alpha are unable to induce antibody-dependent cellular cytotoxicity (ADCC) in murine cells; however, TNF-alpha and IL-1 alpha could substantially augment the ADCC induced by IL-2. IL-1 increased the IL-2-induced ADCC activity in a dose-dependent fashion and in cells isolated from the thymus and spleen. The precursors of the ADCC induced by the combination of IL-1 and IL-2 were asialo GM1+ cells, similar to the precursor cells of IL-2-induced ADCC. The effect of IL-1 and TNF on ADCC was not the result of an increase in the FcR density on the cell surface or the result of an increase in the number of FcR+ cells although IL-1 increased the recovery of viable cells in culture. The main effect of IL-1 and TNF was the enhancement of the lytic ability of the IL-2 cultured cells as indicated by increased intra-cellular benzyloxycarbonyl L-lysine thiobenzylester-esterase activity. These results suggest that lymphokines such as IL-1 and TNF may synergize with IL-2 in the induction of ADCC and could thus potentially be useful for the immunotherapy of established tumors when combined with the administration of specific anti-tumor antibodies.
Similar articles
-
Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.J Immunol. 1990 Jun 1;144(11):4463-71. J Immunol. 1990. PMID: 2111349
-
Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.J Immunol. 1987 Mar 15;138(6):1992-8. J Immunol. 1987. PMID: 3493293
-
Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.Cancer Res. 1988 Mar 1;48(5):1173-9. Cancer Res. 1988. PMID: 3257715
-
Tumor necrosis factor stimulation of neutrophils for antitumor activity.Immunol Ser. 1992;57:523-33. Immunol Ser. 1992. PMID: 1504147 Review. No abstract available.
-
Cytokines in Cancer Immunotherapy.Cold Spring Harb Perspect Biol. 2018 Dec 3;10(12):a028472. doi: 10.1101/cshperspect.a028472. Cold Spring Harb Perspect Biol. 2018. PMID: 29101107 Free PMC article. Review.
Cited by
-
Lung microvascular endothelial cell injury caused by treatment with polymorphonuclear neutrophils and low-IgM serum: a model of transfusion-related acute lung injury.Lung. 2006 Jan-Feb;184(1):25-32. doi: 10.1007/s00408-005-2559-y. Lung. 2006. PMID: 16598649
-
Antitumor effect of recombinant human interleukin-1 beta alone and in combination with natural human tumor necrosis factor-alpha.Jpn J Cancer Res. 1990 Oct;81(10):1026-31. doi: 10.1111/j.1349-7006.1990.tb03341.x. Jpn J Cancer Res. 1990. PMID: 2121675 Free PMC article.
-
A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab.Biomark Res. 2019 Jul 16;7:14. doi: 10.1186/s40364-019-0164-0. eCollection 2019. Biomark Res. 2019. PMID: 31346466 Free PMC article.
-
Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.J Immunother Cancer. 2019 Mar 19;7(1):79. doi: 10.1186/s40425-019-0550-z. J Immunother Cancer. 2019. PMID: 30890189 Free PMC article.
-
Effect of recombinant human tumor necrosis factor alpha on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodules.Cancer Immunol Immunother. 1990;31(4):243-9. doi: 10.1007/BF01789176. Cancer Immunol Immunother. 1990. PMID: 2379220 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources